| dc.contributor.author | Williams, Victor | |
| dc.contributor.author | Onwuchekwa, Chukwuemeka | |
| dc.contributor.author | Grobbee, Diederick E | |
| dc.contributor.author | Otwombe, Kennedy | |
| dc.contributor.author | Klipstein-Grobusch, Kerstin | |
| dc.contributor.editor | Vos, Alinda G | |
| dc.date.accessioned | 2023-07-22T13:04:35Z | |
| dc.date.available | 2023-07-22T13:04:35Z | |
| dc.date.issued | 2022-12 | |
| dc.identifier.citation | Williams V, Onwuchekwa C, Vos AG, Grobbee DE, Otwombe K, Klipstein-Grobusch K. Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021. Glob Health Action. 2022 Dec 31;15(1):2114146. doi: 10.1080/16549716.2022.2114146. PMID: 36178364; PMCID: PMC9543146. | en_US |
| dc.identifier.other | https://doi.org/10.1080/16549716.2022.2114146 | |
| dc.identifier.uri | https://repository.amref.ac.ke/handle/20.500.14173/853 | |
| dc.description.abstract | Hyperglycaemia is a risk factor for tuberculosis. Evidence of changes in blood glucose levels during and after tuberculosis treatment is unclear.
Conclusion: Elevated blood glucose in normoglycaemic patients receiving treatment for tuberculosis decreased by the end of treatment. Positive HIV status did not affect glucose changes during treatment. Further research is needed to investigate post-treatment morbidity in patients with baseline hyperglycaemia and the effects of HIV on the association between blood glucose and tuberculosis. | en_US |
| dc.subject | Diabetes | en_US |
| dc.subject | hyperglycaemia | en_US |
| dc.subject | impaired glucose tolerance | en_US |
| dc.subject | human immunodeficiency virus | en_US |
| dc.title | Tuberculosis Treatment and Resulting Abnormal Blood Glucose: a Scoping Review of Studies from 1981 - 2021 | en_US |
| dc.type | Article, Journal | en_US |
